検索結果

General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...

ng instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingre...

ng instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingre...

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...